Found 51 matching trials
Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy PHASE2 Chemotherapy induced nausea and vomiting (CINV) is a major adverse effect o...
Show More Location
Princess Margaret Hospital
Learn More & Join Trial
Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy PHASE4 Bariatric surgery remains the most effective therapy for obesity. Postopera...
Show More Location
Stony Brook University Hospital
Learn More & Join Trial
Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029) PHASE2 The purpose of this study was to determine the appropriate dosing regimen o...
Show More Location
Multiple Locations
Learn More & Join Trial
Feasibility of Olanzapine at REduced doSe in hIGHly Emetogenic chemoTherapy PHASE3 Olanzapine is frequently used off-label as an adjunct antiemetic in clinica...
Show More Location
Hôpital Charles-LeMoyne
Learn More & Join Trial
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer NA This clinical trial is studying how well granisetron, aprepitant, and dexam...
Show More Location
Sudarshan K Sharma MD Limted-Gynecologic Oncology
Learn More & Join Trial
Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI Trial NA The object of this study is to evaluate the superiority of aprepitant thera...
Show More Location
Kansai Rosai Hospital
Learn More & Join Trial
Odansetron and Dexamethasone Alone vs. Odansetron, Dexamethason and Apreptant to Prevent Nausea PHASE4 The purpose of this study is to compare two different treatment protocols f...
Show More Location
Multiple Locations
Learn More & Join Trial
Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents PHASE3 Chemotherapy-induced nausea and vomiting continues to be a significant prob...
Show More Learn More & Join Trial
Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045) PHASE4 The purpose of this study is to evaluate the safety and tolerability of a 3...
Show More Location
Phoenix Childrens Hospital ( Site 1101)
Learn More & Join Trial
A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer EARLY_PHASE1 This is a non-randomized open-label investigator initiated pilot study comp...
Show More Location
Southern Illinois University School of Medicine
Learn More & Join Trial